These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 18929778)

  • 1. ABO-incompatible adult living donor liver transplantation for hepatocellular carcinoma.
    Matsuno N; Iwamoto H; Nakamura Y; Hama K; Kihara Y; Konno O; Jojima Y; Akashi I; Mijiti A; Ashizawa T; Nagao T
    Transplant Proc; 2008 Oct; 40(8):2497-500. PubMed ID: 18929778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
    Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
    Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
    Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
    Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K
    Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation.
    Kozaki K; Egawa H; Kasahara M; Oike F; Yoshizawa A; Fukatsu A; Tanaka K
    Ther Apher Dial; 2005 Aug; 9(4):285-91. PubMed ID: 16076368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New strategy for ABO-incompatible living donor liver transplantation with anti-CD20 antibody (rituximab) and plasma exchange.
    Kawagishi N; Satoh K; Enomoto Y; Akamatsu Y; Sekiguchi S; Fukumori T; Fujimori K; Satomi S
    Transplant Proc; 2005 Mar; 37(2):1205-6. PubMed ID: 15848670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult living-donor liver transplantation with ABO-incompatible grafts.
    Testa G; Vidanovic V; Chejfec G; Gangemi A; Iqpal R; Porubsky M; Pham T; Benedetti E
    Transplantation; 2008 Mar; 85(5):681-6. PubMed ID: 18337660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up ABO-incompatible adult living donor liver transplantation in cirrhotic patients.
    Matsuno N; Nakamura Y; Mejit A; Hama K; Iwamoto H; Konno O; Jojima Y; Akashi I; Iwahori T; Ashizawa T; Nagao T
    Clin Transplant; 2007; 21(5):638-42. PubMed ID: 17845639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience.
    Kozaki K; Egawa H; Ueda M; Oike F; Yoshizawa A; Fukatsu A; Takada Y
    Ther Apher Dial; 2006 Oct; 10(5):441-8. PubMed ID: 17096700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful case of adult ABO-incompatible liver transplantation: beneficial effects of intrahepatic artery infusion therapy: a case report.
    Nakamura Y; Matsuno N; Iwamoto H; Yokoyama T; Kuzuoka K; Kihara Y; Taira S; Sagara T; Jojima Y; Konno O; Tashiro J; Akashi I; Hama K; Narumi K; Iwahori T; Uchiyama M; Tanaka K; Nagao T
    Transplant Proc; 2004 Oct; 36(8):2269-73. PubMed ID: 15561215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of intraportal donor-specific leukocyte transfusion for adult ABO-incompatible liver transplantation.
    Oya H; Sato Y; Yamamoto S; Nakatsuka H; Kobayashi T; Watanabe T; Hara Y; Kokai H; Hatakeyama K
    Transplant Proc; 2009; 41(1):222-5. PubMed ID: 19249519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases.
    Soejima Y; Muto J; Matono R; Ninomiya M; Ikeda T; Yoshizumi T; Uchiyama H; Ikegami T; Shirabe K; Maehara Y
    Clin Transplant; 2013; 27(2):227-31. PubMed ID: 23293980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.
    Ikegami T; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Harada N; Iguchi T; Hashimoto N; Maehara Y
    Transplantation; 2009 Aug; 88(3):303-7. PubMed ID: 19667930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea.
    Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
    Transplant Proc; 2008 Dec; 40(10):3772-7. PubMed ID: 19100487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New protocol of immunosuppression for liver transplantation across ABO barrier: the use of Rituximab, hepatic arterial infusion, and preservation of spleen.
    Yoshizawa A; Sakamoto S; Ogawa K; Kasahara M; Uryuhara K; Oike F; Ueda M; Takada Y; Egawa H; Tanaka K
    Transplant Proc; 2005 May; 37(4):1718-9. PubMed ID: 15919443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.
    Egawa H; Ohmori K; Haga H; Tsuji H; Yurugi K; Miyagawa-Hayashino A; Oike F; Fukuda A; Yoshizawa J; Takada Y; Tanaka K; Maekawa T; Ozawa K; Uemoto S
    Liver Transpl; 2007 Apr; 13(4):579-88. PubMed ID: 17394164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel approach to successful ABO-incompatible high-titer renal transplantation.
    Uchida J; Iwai T; Kato M; Machida Y; Naganuma T; Kumada N; Yoshimura R; Kawashima H; Kim T; Nakatani T
    Transplant Proc; 2008 Sep; 40(7):2285-8. PubMed ID: 18790213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between recurrences and immunosuppression on living donor liver transplantation for hepatocellular carcinoma.
    Miyagi S; Kawagishi N; Sekiguchi S; Akamatsu Y; Sato K; Takeda I; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
    Transplant Proc; 2012 Apr; 44(3):797-801. PubMed ID: 22483499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoagglutinin adsorption in ABO-incompatible transplantation.
    Genberg H; Kumlien G; Wennberg L; Tydén G
    Transfus Apher Sci; 2010 Oct; 43(2):231-5. PubMed ID: 20667787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors.
    Gloor JM; Lager DJ; Moore SB; Pineda AA; Fidler ME; Larson TS; Grande JP; Schwab TR; Griffin MD; Prieto M; Nyberg SL; Velosa JA; Textor SC; Platt JL; Stegall MD
    Transplantation; 2003 Apr; 75(7):971-7. PubMed ID: 12698082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.